Y-mAbs Therapeutics, Inc. (YMAB)

Y-mAbs Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	550	297	213	707	2,006	1,242
Market Cap Growth	225.29%	39.61%	-69.88%	-64.73%	61.56%	78.51%
Enterprise Value	475	213	101	494	1,879	1,146
Last Close Price	16.26	6.82	4.88	16.21	49.51	31.25
PE Ratio	-	-13.89	-2.23	-12.66	-16.64	-13.57
PS Ratio	6.51	3.51	3.27	20.27	96.67	-
PB Ratio	5.54	2.95	1.95	3.93	18.95	6.24
P/FCF Ratio	-40.48	-10.92	-2.81	-6.85	-21.94	-16.45
P/OCF Ratio	-40.48	-10.92	-2.81	-6.90	-21.99	-16.89
EV/Sales Ratio	5.62	2.51	1.54	14.16	90.55	-
EV/EBITDA Ratio	-26.04	-10.39	-1.22	-4.31	-15.72	-13.83
EV/EBIT Ratio	-25.30	-10.03	-1.21	-4.28	-15.67	-13.80
EV/FCF Ratio	-36.09	-7.81	-1.33	-4.79	-20.56	-15.18
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.04	0.01
Debt / FCF Ratio	-0.07	-0.05	-0.02	-0.04	-0.04	-0.03
Asset Turnover	0.65	0.63	0.37	0.20	0.12	-
Inventory Turnover	1.32	1.94	1.24	-	-	-
Quick Ratio	5.47	5.02	4.18	6.79	5.87	15.25
Current Ratio	6.15	5.52	4.61	7.26	6.26	15.60
Return on Equity (ROE)	-20.93%	-20.39%	-66.06%	-38.66%	-78.32%	-47.74%
Return on Assets (ROA)	-12.02%	-9.83%	-29.40%	-41.84%	-43.03%	-28.17%
Return on Capital (ROIC)	-14.95%	-12.41%	-35.34%	-49.15%	-48.21%	-30.37%
Earnings Yield	-3.94%	-7.20%	-44.85%	-7.81%	-5.95%	-6.53%
FCF Yield	-3.20%	-9.15%	-35.63%	-14.59%	-4.56%	-6.08%
Buyback Yield / Dilution	-0.25%	0.13%	-1.21%	-7.64%	-14.03%	-22.28%
Total Shareholder Return	-0.25%	0.13%	-1.21%	-7.64%	-14.03%	-22.28%

Source: S&P Capital IQ. Standard template.